AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2018

Nov 8, 2018

32870_dirs_2018-11-08_f0aa63a3-98ab-49c0-a939-478a3736069c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-11-06

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-06	Common Stock	S	8000	$68.8992	Disposed	33972	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.34 to $69.27, inclusive.